GeGant

Name: GeGant
Creator: European Medicines Agency
Keywords: applications,authorization,letters,marketing,marketing-authorization,q-a,questions-and-answers,withdrawal

Information

Original link

Type

Miscellaneous

Regulated products

Medical Devices

Last updated

April 26, 2024

Description

Information about marketing authorisation application of GeGant, a device to obtain a solution containing radioactive gallium.

Organization

European Medicines Agency (EMA) 🇪🇺

Country / Region

European Union

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

2 Main files

Questions and answers on the withdrawal of application for the marketing authorisation of GeGant (germanium [68Ge] chloride /gallium [68Ga] chloride)

Updated on April 26, 2024

pdf

URL: https://www.ema.europa.eu/en/documents/medicine-qa/questions-answers-withdrawal-application-marketing-authorisation-gegant-germanium-68ge-chloride-gallium-68ga-chloride_en.pdf
Permalink: https://data.openrid.co/en/datasets/r/16efd669-99b6-405d-90ae-4e1902a73514
MIME Type: application/pdf

Created on: April 26, 2024
Modified on: April 26, 2024

EMA/171931/2024

Withdrawal letter: GeGant